New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
The effective and efficient management of cancer patients relies upon early diagnosis and/or the monitoring of treatment, something that is often difficult to achieve using standard tissue biopsy techniques. Biological fluids such as blood hold great possibilities as a source of non-invasive cancer...
Main Authors: | Erika Larrea, Carla Sole, Lorea Manterola, Ibai Goicoechea, María Armesto, María Arestin, María M. Caffarel, Angela M. Araujo, María Araiz, Marta Fernandez-Mercado, Charles H. Lawrie |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/17/5/627 |
Similar Items
-
Prognostic Stratification of Metastatic Prostate Cancer Patients Treated With Abiraterone and Enzalutamide Through an Integrated Analysis of Circulating Free microRNAs and Clinical Parameters
by: Evgeniya Sharova, et al.
Published: (2021-03-01) -
Clinical Translatability of “Identified” Circulating miRNAs for Diagnosing Breast Cancer: Overview and Update
by: Anna Maria Grimaldi, et al.
Published: (2019-06-01) -
Liquid Biopsy for Cancer Cachexia: Focus on Muscle-Derived microRNAs
by: Roberta Belli, et al.
Published: (2021-08-01) -
Role of Exosomal miRNA in Bladder Cancer: a Promising Liquid Biopsy Biomarker
by: Xuan-Mei Piao, et al.
Published: (2021-02-01) -
MicroRNAs in Metastasis and the Tumour Microenvironment
by: Carla Solé, et al.
Published: (2021-05-01)